Memberships

MetrioPharm

MetrioPharm Memberships

News

Last Patient Last Visit in MetrioPharm’s Phase II Clinical Trial in Psoriasis - 2019-Jun-17

MetrioPharm AG announces that the last patient was now examined during the currently ongoing clinical psoriasis Phase II study (Last Patient Last Visit).

» more

Investor Relations

Investor Relations News QII 2019 - 2019-Jun-26

Topics: 13th Annual General Meeting of MetrioPharm AG, Events, Corporate Calendar of MetrioPharm AG, Employees, blog

» more

Navigation

Home
About us
Technology
Pipeline
Investors
Press
Contact
Blog

Social

  

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Bleicherweg 10
8002 Zurich

Phone: +41 44 562 03 35

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 30 3384 395 02

Imprint
Privacy policy
Sitemap